Methane

Methane

SCHEMBL3572022

C.O=C1OC(N2CCCCC2)C(O)(F)N1c1ccccc1

nearest known ligand 0.38

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.38
TDP1 Q9NUW8 1/20 0.38
MBTD1 Q05BQ5 1/20 0.34
L3MBTL3 Q96JM7 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
FADS1 O60427 1/20 0.34
GAA P10253 1/20 0.33
GRM2 Q14416 1/20 0.33
MEN1 O00255 1/20 0.33
NPC1 O15118 1/20 0.33
RAB9A P51151 1/20 0.33
KMT2A Q03164 1/20 0.33
HRH3 Q9Y5N1 1/20 0.32
HSD11B1 P28845 4/20 0.32
DRD2 P14416 1/20 0.32
DRD3 P35462 1/20 0.32
CYP1A2 P05177 1/20 0.31
CYP2C9 P11712 1/20 0.31
CYP2C19 P33261 1/20 0.31
DDB1 Q16531 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3618028 0.81 ALDH1A1 (0.37) ALDH1A1TDP1MBTD1L3MBTL3L3MBTL1
Methane SCHEMBL3623097 0.66 GRIN1 (0.34) ALDH1A1TDP1L3MBTL1MEN1NPC1
SCHEMBL3572023 0.62 MAOA (0.35) ALDH1A1L3MBTL1FADS1GRM2NPC1
SCHEMBL1843567 0.60 ALDH1A1 (0.43) ALDH1A1TDP1MBTD1L3MBTL3L3MBTL1
SCHEMBL7812799 0.59 ALDH1A1 (0.35) ALDH1A1MEN1NPC1RAB9AKMT2A
Felipyrine SCHEMBL2112111 0.59 ALDH1A1 (0.56) ALDH1A1TDP1MBTD1L3MBTL3L3MBTL1
Propene SCHEMBL3656717 0.59 GRIN1 (0.33) ALDH1A1GAANPC1RAB9AHSD11B1
SCHEMBL3570167 0.58 IDH1 (0.38) ALDH1A1HSD11B1CYP1A2CYP2C9CYP2C19
SCHEMBL5139360 0.58 ALDH1A1 (0.41) ALDH1A1TDP1MBTD1L3MBTL3L3MBTL1
SCHEMBL7814733 0.58 ALDH1A1 (0.41) ALDH1A1TDP1MBTD1L3MBTL3L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8729269-B2 Substituted piperidino phenyloxazolidinones having antimicrobial activity with improved in vivo efficacy WOCKHARDT LIMITED (IN) 2014-05-20 US disclosed
US-20100144735-A1 SUBSTITUTED PIPERIDINO PHENYLOXAZOLIDINONES HAVING ANTIMICROBIAL ACTIVITY WITH IMPROVED IN VIVO EFFICACY WOCKHARDT LIMITED 2010-06-10 US disclosed
US-7687627-B2 Substituted piperidino phenyloxazolidinones having antimicrobial activity with improved in vivo efficacy WOCKHARDT LIMITED (IN) 2010-03-30 US disclosed
EP-1664038-A2 SUBSTITUTED PIPERIDINO PHENYLOXAZOLIDINONES HAVING ANTIMICRIOBIAL ACTIVITY WITH IMPROVED I IN VIVO /I EFFICACY Wockhardt Limited (IN) 2006-06-07 EP disclosed
US-20050143421-A1 Substituted piperidino phenyloxazolidinones having antimicrobial activity with improved in vivo efficacy WOCKHARDT LIMITED 2005-06-30 US disclosed
WO-2005054234-A2 SUBSTITUTED PIPERIDINO PHENYLOXAZOLIDINONES HAVING ANTIMICRIOBIAL ACTIVITY WITH IMPROVED IN VIVO EFFICACY WOCKHARDT LIMITED (IN) 2005-06-16 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100144735-A1 SUBSTITUTED PIPERIDINO PHENYLOXAZOLIDINONES HAVING ANTIMICROBIAL ACTIVITY WITH IMPROVED IN VIVO EFFICACY GMPS, MPO, ARG1 ALDH1A1 1960/4885TDP1 3545/4885MBTD1 1469/4885
US-20050143421-A1 Substituted piperidino phenyloxazolidinones having antimicrobial activity with improved in vivo efficacy GMPS, MPO, ARG1 ALDH1A1 1960/4885TDP1 3545/4885MBTD1 1469/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.